Neovasc Inc.
(Toronto Stock Exchange : NVCN)

( )
NVCN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.95%92.090.6%$542.35m
ABTAbbott Laboratories
0.14%80.050.8%$463.23m
ALGNAlign Technology, Inc.
5.67%280.736.3%$428.01m
TMOThermo Fisher Scientific Inc.
2.10%271.221.0%$396.87m
ISRGIntuitive Surgical, Inc.
1.51%577.982.4%$333.60m
EWEdwards Lifesciences Corporation
1.71%192.131.2%$295.04m
BSXBoston Scientific Corporation
0.82%38.171.1%$278.01m
BDXBecton, Dickinson and Company
0.93%245.401.1%$235.61m
SYKStryker Corporation
0.43%197.981.3%$228.76m
BAXBaxter International Inc.
1.65%78.451.7%$213.43m
DXCMDexCom, Inc.
-2.74%142.168.5%$211.85m
TNDMTandem Diabetes Care, Inc.
2.62%73.564.1%$208.31m
ZBHZimmer Biomet Holdings, Inc.
1.66%129.551.7%$150.14m
WATWaters Corporation
2.07%250.333.5%$139.20m
ABMDABIOMED, Inc.
-0.66%337.433.3%$134.95m

Company Profile

Neovasc, Inc. engages in the development, manufacture, and marketing of medical devices for the cardiovascular marketplace. Its products includes Neovast Tiara and Neovasc Reducer. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.